Sensyne Health PLC (AIM:SENS) (AIM:SENS) CFO Richard Pye joins Proactive London to talk about the news licence and development partner Excalibur has received European regulatory certification for a coronavirus testing system that uses its technology.
The firm will work with Excalibur to roll out the system for lateral flow testing across the UK and Europe.
Excalibur Healthcare Services Limited’s 'Test-To-Go' system includes Excalibur’s CE-marked lateral flow test as well as a CE-marked app, which includes the MagnifEye image analysis technology that provides AI-enabled automated accurate and consistent reading of the test results.